{"artifact":{"id":"open_question-cae3f33d-c521-41eb-a129-de88719231be","artifact_type":"open_question","entity_ids":"[\"researchers\"]","title":"How can Biomarkers, Amyloid, Prevention signals be standardized across cohorts and sites without losing disease-stage sensitivity?","quality_score":0.5,"created_by":"backfill_open_questions","provenance_chain":"[]","content_hash":"7708cf094fc23fe82ef5274a4f0e32dd68052313c640ba812716ceb9cd139fb0","metadata":{"status":"open","_origin":{"url":null,"type":"internal","tracked_at":"2026-04-26T03:29:44.208417"},"field_tag":"researchers","source_id":"researchers-reisa-sperling","sub_field":"reisa-sperling","source_kind":"wiki","question_hash":"e6250a811b449a19cd7a4a9b4d80b0fa3b6dec62496636721f326edfd52098d6","question_text":"How can Biomarkers, Amyloid, Prevention signals be standardized across cohorts and sites without losing disease-stage sensitivity?","importance_elo":1500,"_schema_version":1,"evidence_summary":"Extracted from wiki page researchers-reisa-sperling","evidence_xref_at":"2026-04-27T12:25:56.003629+00:00","tractability_score":0.5,"potential_impact_score":0.5},"created_at":"2026-04-25T20:29:44.208527-07:00","updated_at":"2026-04-25T20:29:44.208527-07:00","version_number":4,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":"2026-04-25T20:29:44.208527-07:00","citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":null,"contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"100b7aa6-a9bc-407c-a7fe-24037e218b34","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"backfill_open_questions"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"wiki-researchers-reisa-sperling","link_type":"derives_from","strength":0.9,"evidence":"{\"method\": \"open_question_wiki_crosslink\", \"cycle\": \"artifact-enrichment-2026-04-27\"}"},{"target_artifact_id":"hypothesis-h-aging-h7-prs-aging-convergence","link_type":"bears_on_question","strength":0.55,"evidence":"{\"confidence\": 0.55, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"},{"target_artifact_id":"hypothesis-h-a20e0cbb","link_type":"bears_on_question","strength":0.42,"evidence":"{\"confidence\": 0.42, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"},{"target_artifact_id":"hypothesis-h-seaad-fa5ea82d","link_type":"bears_on_question","strength":0.48,"evidence":"{\"confidence\": 0.48, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"},{"target_artifact_id":"hypothesis-h-3460f820","link_type":"bears_on_question","strength":0.45,"evidence":"{\"confidence\": 0.45, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"},{"target_artifact_id":"hypothesis-h-b234254c","link_type":"bears_on_question","strength":0.45,"evidence":"{\"confidence\": 0.45, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"},{"target_artifact_id":"experiment_proposal-8c48ed63-08d9-40ff-b2d1-3a27b1c0a6ac","link_type":"partial_answer_for","strength":0.82,"evidence":"{\"confidence\": 0.82, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"},{"target_artifact_id":"experiment-exp-wiki-experiments-blood-biomarker-ad-detection","link_type":"partial_answer_for","strength":0.85,"evidence":"{\"confidence\": 0.85, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"},{"target_artifact_id":"experiment-exp-2267dce9-5cf9-4e2f-a543-e339e9156522","link_type":"discriminating_experiment","strength":0.78,"evidence":"{\"confidence\": 0.78, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"},{"target_artifact_id":"experiment-exp-d003e659-7083-433b-b1e8-b68107d462b1","link_type":"partial_answer_for","strength":0.72,"evidence":"{\"confidence\": 0.72, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"},{"target_artifact_id":"experiment-exp-wiki-experiments-biomarker-guided-therapy-sequencing-ad","link_type":"bears_on_question","strength":0.58,"evidence":"{\"confidence\": 0.58, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"},{"target_artifact_id":"experiment-exp-wiki-experiments-prodromal-parkinson-biomarker-development","link_type":"bears_on_question","strength":0.52,"evidence":"{\"confidence\": 0.52, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"},{"target_artifact_id":"experiment-exp-wiki-experiments-ad-amyloid-resilient-phenotype","link_type":"partial_answer_for","strength":0.68,"evidence":"{\"confidence\": 0.68, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"},{"target_artifact_id":"experiment-exp-wiki-experiments-normal-aging-to-ad-transition","link_type":"partial_answer_for","strength":0.75,"evidence":"{\"confidence\": 0.75, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"},{"target_artifact_id":"experiment-exp-wiki-diagnostics-nph-csf-dynamic-biomarkers-differential-diagnosi","link_type":"bears_on_question","strength":0.55,"evidence":"{\"confidence\": 0.55, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"},{"target_artifact_id":"experiment-exp-wiki-experiments-experiment-index","link_type":"bears_on_question","strength":0.48,"evidence":"{\"confidence\": 0.48, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"}],"incoming_links":[],"current_artifact_id":"open_question-cae3f33d-c521-41eb-a129-de88719231be","is_canonical":true,"supersede_chain":["open_question-cae3f33d-c521-41eb-a129-de88719231be"]}